BRIEF-Acadia Pharmaceuticals Q4 EPS USD 1.6

Reuters
Feb 26
BRIEF-Acadia Pharmaceuticals Q4 EPS USD 1.6

Feb 25 (Reuters) - Acadia Pharmaceuticals Q4 operating expenses USD 266.598 million.

  • Q4 product sales USD 283.989 million
  • Q4 net income USD 273.568 million
  • Q4 pretax profit USD 26.319 million

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10